Gunter Von Minckwitz
nursing
Institut Universitaire des Sciences de lEducation
France
Biography
German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. Electronic address: Gunter.vonMinckwitz@germanbreastgroup.de.
Research Interest
pharmacology
Publications
-
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
